Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Operating Leases (2019 - 2025)

Bio-Techne (TECH) has 7 years of Operating Leases data on record, last reported at $77.2 million in Q4 2025.

  • For Q4 2025, Operating Leases changed N/A year-over-year to $77.2 million; the TTM value through Dec 2025 reached $77.2 million, changed N/A, while the annual FY2025 figure was $84.0 million, 4.17% down from the prior year.
  • Operating Leases reached $77.2 million in Q4 2025 per TECH's latest filing, down from $80.7 million in the prior quarter.
  • Across five years, Operating Leases topped out at $97.3 million in Q3 2023 and bottomed at $58.1 million in Q2 2022.
  • Average Operating Leases over 5 years is $82.2 million, with a median of $84.7 million recorded in 2024.
  • Peak YoY movement for Operating Leases: dropped 14.04% in 2022, then soared 61.3% in 2023.
  • A 5-year view of Operating Leases shows it stood at $65.1 million in 2021, then fell by 10.65% to $58.1 million in 2022, then skyrocketed by 65.19% to $96.0 million in 2023, then dropped by 11.03% to $85.4 million in 2024, then dropped by 9.65% to $77.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $77.2 million in Q4 2025, $80.7 million in Q3 2025, and $84.0 million in Q2 2025.